89bio Inc (ETNB)
8.70
-0.01
(-0.11%)
USD |
NASDAQ |
May 13, 16:00
8.70
0.00 (0.00%)
After-Hours: 17:10
89bio 1 Year Total Returns (Daily): -51.93% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | -51.93% |
May 09, 2024 | -49.58% |
May 08, 2024 | -48.10% |
May 07, 2024 | -43.79% |
May 06, 2024 | -42.47% |
May 03, 2024 | -43.95% |
May 02, 2024 | -43.99% |
May 01, 2024 | -47.38% |
April 30, 2024 | -46.75% |
April 29, 2024 | -46.62% |
April 26, 2024 | -46.74% |
April 25, 2024 | -46.60% |
April 24, 2024 | -45.35% |
April 23, 2024 | -46.55% |
April 22, 2024 | -44.22% |
April 19, 2024 | -48.17% |
April 18, 2024 | -47.98% |
April 17, 2024 | -44.75% |
April 16, 2024 | -39.63% |
April 15, 2024 | -38.85% |
April 12, 2024 | -30.60% |
April 11, 2024 | -29.24% |
April 10, 2024 | -26.86% |
April 09, 2024 | -27.09% |
April 08, 2024 | -27.83% |
Date | Value |
---|---|
April 05, 2024 | -26.60% |
April 04, 2024 | -28.19% |
April 03, 2024 | -28.20% |
April 02, 2024 | -30.53% |
April 01, 2024 | -29.55% |
March 28, 2024 | -30.26% |
March 27, 2024 | -30.83% |
March 26, 2024 | -31.16% |
March 25, 2024 | -30.30% |
March 22, 2024 | -15.94% |
March 21, 2024 | 4.76% |
March 20, 2024 | -3.74% |
March 19, 2024 | -4.18% |
March 18, 2024 | 1.29% |
March 15, 2024 | 5.71% |
March 14, 2024 | -10.57% |
March 13, 2024 | 5.47% |
March 12, 2024 | 7.25% |
March 11, 2024 | 7.42% |
March 08, 2024 | -3.00% |
March 07, 2024 | -0.31% |
March 06, 2024 | -13.67% |
March 05, 2024 | -17.22% |
March 04, 2024 | -2.82% |
March 01, 2024 | -9.40% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.96%
Minimum
Apr 29 2022
764.6%
Maximum
May 09 2023
38.82%
Average
-22.59%
Median
Feb 22 2024
1 Year Total Returns (Daily) Benchmarks
Akero Therapeutics Inc | -58.87% |
Madrigal Pharmaceuticals Inc | -29.74% |
Viking Therapeutics Inc | 224.5% |
Galectin Therapeutics Inc | 67.40% |
Terns Pharmaceuticals Inc | -57.23% |